Geron Corp. (GERN)
NGS · Common · CUSIP 374163103
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for GERN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
374163103
Market Cap
Mid Cap
Business: Geron Corp. is a late-stage clinical biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

Company Contact

CEO
John A. Scarlett M.D.
CFO
Michelle Robertson
Headquarters
919 E. Hillsdale Blvd, Suite 250, Foster City, CA 94404
Phone
650-473-7700
Fax
650-473-7750
Investor Relations
Suzanne Messere · 650-473-7700 · investor@geron.com
General Email
info@geron.com
SEC EDGAR Filings
View filings »